BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27018216)

  • 1. Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets.
    Masuda T; Shimazawa M; Takata S; Nakamura S; Tsuruma K; Hara H
    Exp Eye Res; 2016 May; 146():196-205. PubMed ID: 27018216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
    Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
    Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells.
    Li X; Cai Y; Wang YS; Shi YY; Hou W; Xu CS; Wang HY; Ye Z; Yao LB; Zhang J
    PLoS One; 2012; 7(10):e47600. PubMed ID: 23094067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.
    Monaghan-Benson E; Hartmann J; Vendrov AE; Budd S; Byfield G; Parker A; Ahmad F; Huang W; Runge M; Burridge K; Madamanchi N; Hartnett ME
    Am J Pathol; 2010 Oct; 177(4):2091-102. PubMed ID: 20802176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice.
    Tan X; Takahashi H; Nishida J; Aoki A; Inoue T; Yanagi Y
    Exp Eye Res; 2015 Feb; 131():77-83. PubMed ID: 25576666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
    Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
    Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
    Wang H; Han X; Wittchen ES; Hartnett ME
    Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
    Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H
    Mol Vis; 2018; 24():83-93. PubMed ID: 29422766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
    Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
    Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration.
    Kaneko H; Ye F; Ijima R; Kachi S; Kato S; Nagaya M; Higuchi A; Terasaki H
    Br J Pharmacol; 2014 Aug; 171(15):3754-63. PubMed ID: 24787705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).
    Masuda T; Shimazawa M; Hara H
    Oxid Med Cell Longev; 2017; 2017():9208489. PubMed ID: 28194256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin on models of retinal pigment epithelium pathology.
    Goyal S; Lyzogubov VV; Ali O; Bora PS; Bora NS; Uwaydat SH
    Clin Exp Ophthalmol; 2016 Sep; 44(7):610-617. PubMed ID: 26861462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of choroidal neovascularization by N-acetyl-cysteine in mice.
    Hara R; Inomata Y; Kawaji T; Sagara N; Inatani M; Fukushima M; Tanihara H
    Curr Eye Res; 2010 Nov; 35(11):1012-20. PubMed ID: 20958190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
    Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
    J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model.
    Zhang ZX; Wang YS; Shi YY; Hou HY; Zhang C; Cai Y; Dou GR; Yao LB; Li FY
    Curr Eye Res; 2011 Sep; 36(9):838-49. PubMed ID: 21851170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.